Autoimmunity in myocardial infarction

被引：69

作者：

Liao, Yu-Hua ^{[1
]}

Cheng, Xiang ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Lab Cardiovasc Immunol,Inst Cardiol, Wuhan 430022, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2006年 / 112卷 / 01期

关键词：

myocardial infarction; ventricular remodeling; immune therapy;

D O I：

10.1016/j.ijcard.2006.05.009

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Myocardial infarction is associated with an immune response. Physiological inflammation response causes self-repair and protection, while pathological autoimmune response leads to ventricular remodeling and heart failure. Laying emphasis on regulating the immune function may become a new target for the prevention of heart failure after myocardial infarction. This review focuses on the mechanism of immune-mediated ventricular remodeling and the immune therapy after myocardial infarction. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：21 / 26

页数：6

相关论文

共 61 条

[1]

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J].

Bauersachs, J ;

Galuppo, P ;

Fraccarollo, D ;

Christ, M ;

Ertl, G .

CIRCULATION, 2001, 104 (09) :982-985

[2]

C-Reactive protein in acute myocardial infarction: Association with heart failure [J].

Berton, G ;

Cordiano, R ;

Palmieri, R ;

Pianca, S ;

Pagliara, V ;

Palatini, P .

AMERICAN HEART JOURNAL, 2003, 145 (06) :1094-+

[3]

Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice [J].

Blankesteijn, WM ;

Creemers, E ;

Lutgens, E ;

Cleutjens, JPM ;

Daemen, MJAP ;

Smits, JFM .

ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 173 (01) :75-82

[4]

A class of counterexamples concerning an open problem [J].

Chen, PX ;

Lu, SM .

ACTA MATHEMATICA SINICA-ENGLISH SERIES, 2005, 21 (01) :9-12

[5]

Effects of Atorvastatin on Th polarization in patients with acute myocardial infarction [J].

Cheng, X ;

Liao, YH ;

Zhang, JY ;

Lin, B ;

Ge, HX ;

Yuan, J ;

Wang, M ;

Lu, BJ ;

Liu, Y ;

Cheng, Y .

EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (07) :1099-1104

[6]

Th1/Th2 functional imbalance after acute myocardial infarction: Coronary arterial inflammation or myocardial inflammation [J].

Cheng, X ;

Liao, YH ;

Ge, HX ;

Li, B ;

Zhang, JY ;

Yuan, J ;

Wang, M ;

Liu, Y ;

Guo, ZQ ;

Chen, J ;

Zhang, J ;

Zhang, LJ .

JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (03) :246-253

[7]

CHENG X, 2005, J HONG KONG COLL CAR, V13, P98

[8]

Cheng Xiang, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P448

[9]

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].

Chung, ES ;

Packer, M ;

Lo, KH ;

Fasanmade, AA ;

Willerson, JT .

CIRCULATION, 2003, 107 (25) :3133-3140

[10]

Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy [J].

Cinquegrana, G ;

D'Aniello, L ;

Landi, M ;

Spinelli, L ;

Grande, G ;

De Prisco, F ;

Petretta, M .

JOURNAL OF CARDIAC FAILURE, 2005, 11 (03) :213-219

← 1 2 3 4 5 6 7 →